Skip to content

Comparison of rosavastatin and atorvastatin on insulin resistance

Comparison of rosavastatin and atorvastatin on insulin resistance In patients with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140514017686N2
Enrollment
60
Registered
2022-08-18
Start date
2022-09-01
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: Atorvastatin 40 mg, orally, once daily, for 12 weeks. Intervention 2: Intervention group: Rosuvastatin 20 mg, orally, once daily for 12 weeks.

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having type 2 diabetes low-density lipoprotein (LDL) serum level above 70

Exclusion criteria

Exclusion criteria: Having cardiovascular diseases Obvious liver disease and chronic kidney failure Uncontrolled diabetes Very High blood pressure Corticosteroid use

Design outcomes

Primary

MeasureTime frame
Insulin resistance. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Homeostatic Model Assessment for Insulin Resistance calculation formula (HOMA-IR).

Secondary

MeasureTime frame
Fasting blood sugar. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Blood test.;Serum insulin levels. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmoud Parham

Ghoum University of Medical Sciences

drparham@muq.ac.ir+98 25 3612 2952

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026